Autocrine effects of PCSK9 on cardiomyocytes

被引：24

作者：

Wolf, Annemarie ^{[1
]}

Kutsche, Hanna Sarah ^{[1
]}

Schreckenberg, Rolf ^{[1
]}

Weber, Martin ^{[1
]}

Li, Ling ^{[1
]}

Rohrbach, Susanne ^{[1
]}

Schulz, Rainer ^{[1
]}

Schlueter, Klaus-Dieter ^{[1
]}

机构：

[1] Justus Liebig Univ Giessen, Inst Physiol, Aulweg 129, D-35392 Giessen, Germany

来源：

BASIC RESEARCH IN CARDIOLOGY | 2020年 / 115卷 / 06期

关键词：

PCSK9; Cardiomyocytes; Cardiac function; oxLDL; Cardiovascular disease; LOW-DENSITY-LIPOPROTEIN; ISCHEMIC-HEART-DISEASE; RECEPTOR; LDL; CHOLESTEROL; EXPRESSION; INHIBITORS; RISK;

D O I：

10.1007/s00395-020-00824-w

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Proprotein convertase subtilisin kexin type 9 (PCSK9) is in the focus of cardiovascular research due to its role in hepatic low density lipoprotein (LDL) clearance. However, extrahepatic expression of PCSK9 such as in cardiomyocytes and its regulation by oxidized LDL (oxLDL) put notion on extrahepatic effects of PCSK9 as well. This study was aimed to reveal the role of PCSK9 in oxLDL-dependent regulation of cardiomyocyte function. Adult rat and mouse ventricular cardiomyocytes and isolated perfused hearts were used. OxLDL was applied to increase PCSK9 expression in cardiomyocytes. Cell function was analyzed by load-free cell shortening as well as left ventricular developed pressure of isolated hearts. OxLDL decreased shortening in wild-type-derived mouse cardiomyocytes but not in those isolated from PCSK9 knockout mice. Overexpression of human PCSK9 in rat cardiomyocytes reduced shortening in the absence of oxLDL. Addition of recombinant PCSK9 mimicked these effects. In cardiomyocytes, oxLDL induced PCSK9 release into the supernatant. Inhibition of PCSK9 by Pep 2-8 or alirocumab attenuated the oxLDL-induced loss of cardiomyocyte shortening. Cardiomyocytes express surfeit locus protein 4 (SURF-4), a protein required for PCSK9 secretion in human embryonic kidney cells (HEK 293 T), and silencing of SURF-4 reduced the oxLDL effects on cardiomyocytes. In isolated perfused rat hearts PCSK9 inhibition by alirocumab improved the function. In addition, left ventricular function of isolated hearts from PCSK9 knockout mice was increased under basal conditions as well as at 10 min and 120 min of reperfusion following 45 min of ischemia. Collectively, the data show that cardiomyocytes express and release PCSK9 that acts in an autocrine way on cardiomyocytes and impairs their function.

引用

页数：13

共 38 条

[1] Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longitudinal Study [J].

Abdullah, Shuaib M. ;

Defina, Laura F. ;

Leonard, David ;

Barlow, Carolyn E. ;

Radford, Nina B. ;

Willis, Benjamin L. ;

Rohatgi, Anand ;

McGuire, Darren K. ;

de Lemos, James A. ;

Grundy, Scott M. ;

Berry, Jarett D. ;

Khera, Amit .

CIRCULATION, 2018, 138 (21) :2315-2325

[2] Mutations in PCSK9 cause autosomal dominant hypercholesterolemia [J].

Abifadel, M ;

Varret, M ;

Rabès, JP ;

Allard, D ;

Ouguerram, K ;

Devillers, M ;

Cruaud, C ;

Benjannet, S ;

Wickham, L ;

Erlich, D ;

Derré, A ;

Villéger, L ;

Farnier, M ;

Beucler, I ;

Bruckert, E ;

Chambaz, J ;

Chanu, B ;

Lecerf, JM ;

Luc, G ;

Moulin, P ;

Weissenbach, J ;

Prat, A ;

Krempf, M ;

Junien, C ;

Seidah, NG ;

Boileau, C .

NATURE GENETICS, 2003, 34 (02) :154-156

[3] The effects of proprotein convertase subtilisin/kexin type 9 inhibitors on lipid metabolism and cardiovascular function [J].

Amput, Patchareeya ;

McSweeney, Christian ;

Palee, Siripong ;

Phrommintikul, Arintaya ;

Chattipakorn, Siriporn C. ;

Chattipakorn, Nipon .

BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 :1171-1180

[4] PCSK9 R46L, Low-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease 3 Independent Studies and Meta-Analyses [J].

Benn, Marianne ;

Nordestgaard, Borge G. ;

Grande, Peer ;

Schnohr, Peter ;

Tybjaerg-Hansen, Anne .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (25) :2833-2842

[5] Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection [J].

Botker, Hans Erik ;

Hausenloy, Derek ;

Andreadou, Ioanna ;

Antonucci, Salvatore ;

Boengler, Kerstin ;

Davidson, Sean M. ;

Deshwal, Soni ;

Devaux, Yvan ;

Di Lisa, Fabio ;

Di Sante, Moises ;

Efentakis, Panagiotis ;

Femmino, Saveria ;

Garcia-Dorado, David ;

Giricz, Zoltan ;

Ibanez, Borja ;

Iliodromitis, Efstathios ;

Kaludercic, Nina ;

Kleinbongard, Petra ;

Neuhaeuser, Markus ;

Ovize, Michel ;

Pagliaro, Pasquale ;

Rahbek-Schmidt, Michael ;

Ruiz-Meana, Marisol ;

Schlueter, Klaus-Dieter ;

Schulz, Rainer ;

Skyschally, Andreas ;

Wilder, Catherine ;

Yellon, Derek M. ;

Ferdinandy, Peter ;

Heusch, Gerd .

BASIC RESEARCH IN CARDIOLOGY, 2018, 113 (05)

[6]

Chaudhary R, 2017, WORLD J CARDIOL, V9, P76, DOI 10.4330/wjc.v9.i2.76

[7] Sequence variations in PCSK9, low LDL, and protection against coronary heart disease [J].

Cohen, JC ;

Boerwinkle, E ;

Mosley, TH ;

Hobbs, HH .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (12) :1264-1272

[8] PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor [J].

Da Dalt, Lorenzo ;

Ruscica, Massimiliano ;

Bonacina, Fabrizia ;

Balzarotti, Gloria ;

Dhyani, Ashish ;

Di Cairano, Eliana ;

Baragetti, Andrea ;

Arnaboldi, Lorenzo ;

De Metrio, Simona ;

Pellegatta, Fabio ;

Grigore, Liliana ;

Botta, Margherita ;

Macchi, Chiara ;

Uboldi, Patrizia ;

Perego, Carla ;

Catapano, Alberico Luigi ;

Norata, Giuseppe Danilo .

EUROPEAN HEART JOURNAL, 2019, 40 (04) :357-U61

[9] PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy [J].

Ding, Zufeng ;

Wang, Xianwei ;

Liu, Shijie ;

Shahanawaz, Jiwani ;

Theus, Sue ;

Fan, Yubo ;

Deng, Xiaoyan ;

Zhou, Sichang ;

Mehta, Jawahar L. .

CARDIOVASCULAR RESEARCH, 2018, 114 (13) :1738-1751

[10] The cargo receptor SURF4 promotes the efficient cellular secretion of PCSK9 [J].

Emmer, Brian T. ;

Hesketh, Geoffrey G. ;

Kotnik, Emilee ;

Tang, Vi T. ;

Lascuna, Paul J. ;

Xiang, Jie ;

Gingras, Anne-Claude ;

Chen, Xiao-Wei ;

Ginsburg, David .

ELIFE, 2018, 7

← 1 2 3 4 →